Literature DB >> 20388696

Oligodendroglioma cell lines containing t(1;19)(q10;p10).

John J P Kelly1, Michael D Blough, Owen D M Stechishin, Jennifer A W Chan, Desiree Beauchamp, Marco Perizzolo, Doug J Demetrick, Lisa Steele, Roland N Auer, Walter J Hader, Morgan Westgate, Ian F Parney, Robert Jenkins, J Gregory Cairncross, Samuel Weiss.   

Abstract

Investigating the biology of oligodendroglioma and its characteristic combined deletion of chromosomal arms 1p and 19q, mediated by an unbalanced translocation, t(1;19)(q10;p10), has been hampered by the lack of cell lines that harbor these traits. We grew cells from 2 anaplastic oligodendrogliomas in serum-free conditions. Serial propagation and expansion led to the establishment of permanent cell lines that maintained the genetic signature of the parent oligodendrogliomas and displayed features of brain tumor stem cells in vitro. One line was established from a treatment-naïve tumor and the other from a temozolomide resistant recurrent tumor. These lines may be important tools for understanding the biology of oligodendrogliomas and the function of their defining genetic traits.

Entities:  

Mesh:

Year:  2010        PMID: 20388696      PMCID: PMC2940664          DOI: 10.1093/neuonc/noq031

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  22 in total

1.  Direct isolation of human central nervous system stem cells.

Authors:  N Uchida; D W Buck; D He; M J Reitsma; M Masek; T V Phan; A S Tsukamoto; F H Gage; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

2.  A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma.

Authors:  Robert B Jenkins; Hilary Blair; Karla V Ballman; Caterina Giannini; Robert M Arusell; Mark Law; Heather Flynn; Sandra Passe; Sara Felten; Paul D Brown; Edward G Shaw; Jan C Buckner
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

3.  Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss.

Authors:  Constance A Griffin; Peter Burger; Laura Morsberger; Raluca Yonescu; Sharon Swierczynski; Jon D Weingart; Kathleen M Murphy
Journal:  J Neuropathol Exp Neurol       Date:  2006-10       Impact factor: 3.685

4.  Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.

Authors:  Gregory Cairncross; Brian Berkey; Edward Shaw; Robert Jenkins; Bernd Scheithauer; David Brachman; Jan Buckner; Karen Fink; Luis Souhami; Normand Laperierre; Minesh Mehta; Walter Curran
Journal:  J Clin Oncol       Date:  2006-06-20       Impact factor: 44.544

5.  Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics.

Authors:  Arie Perry; Christine E Fuller; Ruma Banerjee; Daniel J Brat; Bernd W Scheithauer
Journal:  Front Biosci       Date:  2003-01-01

6.  Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma.

Authors:  Rossella Galli; Elena Binda; Ugo Orfanelli; Barbara Cipelletti; Angela Gritti; Simona De Vitis; Roberta Fiocco; Chiara Foroni; Francesco Dimeco; Angelo Vescovi
Journal:  Cancer Res       Date:  2004-10-01       Impact factor: 12.701

7.  An integrated genomic analysis of human glioblastoma multiforme.

Authors:  D Williams Parsons; Siân Jones; Xiaosong Zhang; Jimmy Cheng-Ho Lin; Rebecca J Leary; Philipp Angenendt; Parminder Mankoo; Hannah Carter; I-Mei Siu; Gary L Gallia; Alessandro Olivi; Roger McLendon; B Ahmed Rasheed; Stephen Keir; Tatiana Nikolskaya; Yuri Nikolsky; Dana A Busam; Hanna Tekleab; Luis A Diaz; James Hartigan; Doug R Smith; Robert L Strausberg; Suely Kazue Nagahashi Marie; Sueli Mieko Oba Shinjo; Hai Yan; Gregory J Riggins; Darell D Bigner; Rachel Karchin; Nick Papadopoulos; Giovanni Parmigiani; Bert Vogelstein; Victor E Velculescu; Kenneth W Kinzler
Journal:  Science       Date:  2008-09-04       Impact factor: 47.728

8.  Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens.

Authors:  John J P Kelly; Owen Stechishin; Andrew Chojnacki; Xueqing Lun; Beichen Sun; Donna L Senger; Peter Forsyth; Roland N Auer; Jeff F Dunn; J Gregory Cairncross; Ian F Parney; Samuel Weiss
Journal:  Stem Cells       Date:  2009-08       Impact factor: 6.277

9.  Identification of a cancer stem cell in human brain tumors.

Authors:  Sheila K Singh; Ian D Clarke; Mizuhiko Terasaki; Victoria E Bonn; Cynthia Hawkins; Jeremy Squire; Peter B Dirks
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

10.  IDH1 and IDH2 mutations in gliomas.

Authors:  Hai Yan; D Williams Parsons; Genglin Jin; Roger McLendon; B Ahmed Rasheed; Weishi Yuan; Ivan Kos; Ines Batinic-Haberle; Siân Jones; Gregory J Riggins; Henry Friedman; Allan Friedman; David Reardon; James Herndon; Kenneth W Kinzler; Victor E Velculescu; Bert Vogelstein; Darell D Bigner
Journal:  N Engl J Med       Date:  2009-02-19       Impact factor: 176.079

View more
  43 in total

1.  An in vivo patient-derived model of endogenous IDH1-mutant glioma.

Authors:  H Artee Luchman; Owen D Stechishin; N Ha Dang; Michael D Blough; Charles Chesnelong; John J Kelly; Stephanie A Nguyen; Jennifer A Chan; Aalim M Weljie; J Gregory Cairncross; Samuel Weiss
Journal:  Neuro Oncol       Date:  2011-12-13       Impact factor: 12.300

2.  IDH1 Mutation Induces Reprogramming of Pyruvate Metabolism.

Authors:  Jose L Izquierdo-Garcia; Pavithra Viswanath; Pia Eriksson; Larry Cai; Marina Radoul; Myriam M Chaumeil; Michael Blough; H Artee Luchman; Samuel Weiss; J Gregory Cairncross; Joanna J Phillips; Russell O Pieper; Sabrina M Ronen
Journal:  Cancer Res       Date:  2015-06-04       Impact factor: 12.701

3.  Primary orthotopic glioma xenografts recapitulate infiltrative growth and isocitrate dehydrogenase I mutation.

Authors:  J Geraldo Valadez; Anuraag Sarangi; Christopher J Lundberg; Michael K Cooper
Journal:  J Vis Exp       Date:  2014-01-14       Impact factor: 1.355

4.  Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1.

Authors:  Tali Mazor; Charles Chesnelong; Aleksandr Pankov; Llewellyn E Jalbert; Chibo Hong; Josie Hayes; Ivan V Smirnov; Roxanne Marshall; Camila F Souza; Yaoqing Shen; Pavithra Viswanath; Houtan Noushmehr; Sabrina M Ronen; Steven J M Jones; Marco A Marra; J Gregory Cairncross; Arie Perry; Sarah J Nelson; Susan M Chang; Andrew W Bollen; Annette M Molinaro; Henrik Bengtsson; Adam B Olshen; Samuel Weiss; Joanna J Phillips; H Artee Luchman; Joseph F Costello
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-15       Impact factor: 11.205

5.  Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas.

Authors:  Hiroaki Wakimoto; Shota Tanaka; William T Curry; Franziska Loebel; Dan Zhao; Kensuke Tateishi; Juxiang Chen; Lindsay K Klofas; Nina Lelic; James C Kim; Dora Dias-Santagata; Leif W Ellisen; Darrell R Borger; Sarah-Maria Fendt; Matthew G Vander Heiden; Tracy T Batchelor; A John Iafrate; Daniel P Cahill; Andrew S Chi
Journal:  Clin Cancer Res       Date:  2014-04-08       Impact factor: 12.531

6.  2-Hydroxyglutarate-Mediated Autophagy of the Endoplasmic Reticulum Leads to an Unusual Downregulation of Phospholipid Biosynthesis in Mutant IDH1 Gliomas.

Authors:  Pavithra Viswanath; Marina Radoul; Jose Luis Izquierdo-Garcia; Wei Qiang Ong; Hema Artee Luchman; J Gregory Cairncross; Bo Huang; Russell O Pieper; Joanna J Phillips; Sabrina M Ronen
Journal:  Cancer Res       Date:  2018-01-22       Impact factor: 12.701

7.  Identification of Hedgehog pathway responsive glioblastomas by isocitrate dehydrogenase mutation.

Authors:  J Gerardo Valadez; Vandana K Grover; Melissa D Carter; M Wade Calcutt; Sunday A Abiria; Christopher J Lundberg; Thomas V Williams; Michael K Cooper
Journal:  Cancer Lett       Date:  2012-10-11       Impact factor: 8.679

8.  Modulation of the Wnt/beta-catenin pathway in human oligodendroglioma cells by Sox17 regulates proliferation and differentiation.

Authors:  Hui-Ling Chen; Li-Jin Chew; Roger J Packer; Vittorio Gallo
Journal:  Cancer Lett       Date:  2013-03-06       Impact factor: 8.679

9.  Lactate dehydrogenase A silencing in IDH mutant gliomas.

Authors:  Charles Chesnelong; Myriam M Chaumeil; Michael D Blough; Mohammad Al-Najjar; Owen D Stechishin; Jennifer A Chan; Russell O Pieper; Sabrina M Ronen; Samuel Weiss; H Artee Luchman; J Gregory Cairncross
Journal:  Neuro Oncol       Date:  2013-12-22       Impact factor: 12.300

10.  Disruption of wild-type IDH1 suppresses D-2-hydroxyglutarate production in IDH1-mutated gliomas.

Authors:  Genglin Jin; Zachary J Reitman; Christopher G Duncan; Ivan Spasojevic; David M Gooden; B Ahmed Rasheed; Rui Yang; Giselle Y Lopez; Yiping He; Roger E McLendon; Darell D Bigner; Hai Yan
Journal:  Cancer Res       Date:  2012-11-30       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.